January

1. Lupia, A.; Mimmi, S.; Iaccino, E.; Maisano, D.; Moraca, F.; Talarico, C.; Vecchio, E.; Fiume, G.; Ortuso, F.; Scala, G.; Quinto, I.; Alcaro, S.; Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia. Eur J Med Chem 2020, 185, 111838. DOI: 10.1016/j.ejmech.2019.111838

2. Bagetta, D.; Maruca, A.; Lupia, A.; Mesiti, F.; Catalano, R.; Romeo, I.; Moraca, F.; Ambrosio, FA.; Costa, G.; Artese, A.; Ortuso, F.; Alcaro, S.; Rocca R. Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome. Eur J Med Chem 2020, 186, 111903. DOI: 10.1016/j.ejmech.2019.111903

3. Volpe, SD.; Listro, R.; Parafioriti, M.; Di Giacomo, M.; Rossi, D.; Ambrosio, FA.; Costa, G.; Alcaro, S.; Ortuso, F.; Hirsch, AKH.; Vasile, F.; Collina, S. BOPC1 Enantiomers Preparation and HuR Interaction Study. From Molecular Modeling to a Curious DEEP-STD NMR Application. ACS Med Chem Lett 202011, 883-888. DOI: 10.1021/acsmedchemlett.9b00659

4. Morelli, E.; Gullà, A.; Rocca, R.; Federico, C.; Raimondi, L.; Malvestiti, S.; Agosti, V.; Rossi, M.; Costa, G.; Giavaresi, G.; Azab, AK.; Cagnetta, A.; Cea, M.; Tagliaferri, P.; Neri, A.; Munshi, NC.; Viglietto, G.; Tassone, P.; Amodio, N. The non-coding RNA landscape of plasma cell dyscrasias. Cancers 2020, 12, 320. DOI: 10.3390/cancers12020320

 

February

5. Rocca, R.; Palazzesi, F.; Amato, J.; Costa, G.; Ortuso, F.; Pagano, B.; Randazzo, A.; Novellino, E.; Alcaro, S.; Moraca F.; Artese, A. Folding intermediate states of the parallel human telomeric G-quadruplex DNA explored using Well-Tempered Metadynamics. Sci Rep 2020, 10, 1-11. DOI: 10.1038/s41598-020-59774-x

 

May

6. Maruca, A.; Lanzillotta, D.; Rocca, R.; Lupia, A.; Costa, G.; Catalano, R.; Moraca, F.; Gaudio, E.; Artese, A.; Trapasso, F.; Alcaro, S. Multi-Targeting Bioactive Compounds Extracted from Essential Oils as Kinase Inhibitors. Molecules 202025, 2174. DOI: 10.3390/molecules25092174

7. Marques, CS.; López, Ó.; Bagetta, D.; Carreiro, EP.; Petralla, S.; Bartolini, M.; Hoffmann, M.; Alcaro, S.; Monti, B.; Bolognesi, ML.; Decker, M.; Fernández-Bolaños, JG.; Burke, JA. N-1, 2, 3-triazole-isatin derivatives for cholinesterase and β-amyloid aggregation inhibition: A comprehensive bioassay study. Bioorg Chem 2020, 98, 103753. DOI: 10.1016/j.bioorg.2020.103753

 

June

8. Grillone, K.; Riillo, C.; Scionti, F.; Rocca, R.; Tradigo, G.; Guzzi, PH.; Alcaro, S.; Di Martino, MT.; Tagliaferri, P.; Tassone, P. Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter”. J Exp Clin Cancer Res 2020, 39, 1-19. DOI: 10.1186/s13046-020-01622-x

 

July

 

9. Bortolami, M.; Pandolfi, F.; De Vita, D.; Carafa, C.; Messore, A.; Di Santo, R.; Feroci, M.; Costi, R.; Chiarotto, I.; Bagetta, D.; Alcaro, S.; Colone, M.; Stringano, A.; Scipione, L. New deferiprone derivatives as multi-functional cholinesterase inhibitors: design, synthesis and in vitro evaluation. Eur J Med Chem 2020, 198, 112350. DOI: 10.1016/j.ejmech.2020.112350

10. Coricello, A.; Mesiti, F.; Lupia, A.; Maruca, A.; Alcaro, S. Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates. Molecules 2020, 25, 3321. DOI: 10.3390/molecules25153321

 

August

11. Radadiya, A.; Zhu, W.; Coricello, A.; Alcaro, S.; Richards, N. G. Improving the Treatment of Acute Lymphoblastic Leukemia. Biochemistry 202059, 3193-3200. DOI: 10.1021/acs.biochem.0c00354

 

12. Costa, G.; Maruca, A.; Rocca, R.; Ambrosio, F. A.; Berrino, E.; Carta, F.; Mesiti, F.; Salatino, A.; Lanzillotta, D.; Trapasso, F.; Artese, A.; Alcaro, S.; Supuran, TS. In silico identification and biological evaluation of antioxidant food components endowed with IX and XII hCA inhibition. Antioxidants 20209, 775. DOI: 10.3390/antiox9090775

13. Scumaci, D.; Olivo, E.; Fiumara, C. V.; La Chimia, M.; De Angelis, MT.; Mauro, S.; Costa, G.; Ambrosio, FA.; Alcaro, S.; Agosti, V.; Costanzo, FS.; Cuda, G. DJ-1 Proteoforms in Breast Cancer Cells: The Escape of Metabolic Epigenetic Misregulation. Cells 20209, 1968. DOI: 10.3390/cells9091968

 

September

14. Spanò, V.; Rocca, R.; Barreca, M.; Giallombardo, D.; Montalbano, A.; Carbone, A.; Raimondi, M.V.; Gaudio, E.; Bortolozzi, R.; Ruoli, B.; Tassone, P.; Alcaro, S.; Hamel, E.; Viola, G.; Bertoni, F.; Barraja, P. Pyrrolo [2′, 3′: 3, 4] Cyclohepta [1, 2-D][1, 2] Oxazoles, a new class of Antimitotic Agents, active against multiple malignant cell types. J Med Chem 2020, 63, 12023-12042. DOI: 10.1021/acs.jmedchem.0c01315

 

October

15. Carino, A.; Moraca, F.; Fiorillo, B.; Marchianò, S.; Sepe, V.; Biagioli, M.; Finamore, C.; Bozza, S.; Francisci, D.; Distrutti, E.; Catalanotti, B.; Zampella A. and Fiorucci, S. Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain. Front Chem 2020, 8, 572885. DOI: doi.org/10.3389/fchem.2020.572885

 

December

16. Artese, A.; Svicher, V.; Costa, G.; Salpini, R.; Di Maio, V.C.; Alkhatib, M.; Ambrosio, F.A.; Santoro, M.M.; Assaraf, Y.G.; Alcaro, S.; Ceccherini-Silberstein, F. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Drug Resist Updat 202053, 100721. DOI: 10.1016/j.drup.2020.100721